Viewing Study NCT01262469


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2026-01-01 @ 4:48 PM
Study NCT ID: NCT01262469
Status: COMPLETED
Last Update Posted: 2014-12-16
First Post: 2010-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.
Sponsor: UNICANCER
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GERICO 09/0907
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View